Franklin, Parlapiano, Turner & Welch’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Hold
594
0.16% 41
2026
Q1
$545K Hold
594
0.13% 41
2025
Q4
$617K Hold
594
0.15% 40
2025
Q3
$453K Hold
594
0.11% 42
2025
Q2
$463K Hold
594
0.12% 40
2025
Q1
$491K Hold
594
0.13% 40
2024
Q4
$459K Sell
594
-16
-3% -$13.2K 0.12% 41
2024
Q3
$540K Buy
610
+16
+3% +$14.4K 0.14% 40
2024
Q2
$538K Hold
594
0.15% 39
2024
Q1
$462K Hold
594
0.13% 39
2023
Q4
$346K Hold
594
0.1% 41
2023
Q3
$319K Hold
594
0.1% 44
2023
Q2
$279K Buy
+594
New +$249K 0.08% 44

Other funds holding LLY

Franklin, Parlapiano, Turner & Welch's LLY Position: Q2 2026 in Review

Franklin, Parlapiano, Turner & Welch held its Eli Lilly (LLY) position steady in Q2 2026 at 594 shares worth $712K. The position accounts for 0.16% of the portfolio, ranked #41.

Franklin, Parlapiano, Turner & Welch first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Franklin, Parlapiano, Turner & Welch held 594 shares of Eli Lilly worth $712K as of Q2 2026.
  • Franklin, Parlapiano, Turner & Welch left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.16% of Franklin, Parlapiano, Turner & Welch's portfolio in Q2 2026, its #41 holding.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2026, filed 9 Jul 2026.